India’s first quadrivalent flu vaccine to offer better protection against influenza A and B strains. Experts stress the ...

Zydus Lifesciences on Wednesday said it is introducing a vaccine for protection against new strain of influenza virus.

A global collaboration towards a secure supply-chain or a differentiated manufacturing model are just some of the options ...

New Delhi: Accepting the bioequivalence study report for Type 2 Diabetes Mellitus, the Subject Expert Committee (SEC) ...

Zydus Lifesciences to launch VaxiFlu-4 vaccine for 2025 southern hemisphere, offering broad protection against influenza ...

Zydus Lifesciences introduces India's first quadrivalent influenza vaccine, VaxiFlu-4, offering protection against four new ...

Zydus on Wednesday announced that it is ready to launch the season’s first India’s Flu protection as per WHO recommended ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

The Indian pharmaceutical industry has the potential to deliver 100 new drugs for global markets by 2047, driven by enhanced ...

Zydus Lifesciences on Wednesday said it is introducing a vaccine for protection against a new strain of influenza virus. The ...

India's first quadrivalent influenza vaccine, for the 2025 southern hemisphere season. A quadrivalent vaccine, by covering strains of both influenza A and influenza B, provides broader protection and ...